Article PDF
Selected references
Adamec RE. Evidence of lasting potentiation of amygdala efferents in the right hemisphere underlies pharmacological stressor (FG-7142) induced lasting increases in anxiety-like behavior: role of GABA tone in initiation of brain and behavioral changes. J Psychopharm 2000; 14: 323–39.
Berde CB. New and old anticonvulsants for management of pain. Technical Corner from IASP Newsletter 1997.
Beydoun A, Backonja MM. Mechanistic stratification of antineuralgic analgesics. J Pain Symptom Manage 2003; 25: S18–30.
International Association for the Study of Pain: IASP pain terminology. Classification of pain. In: Mersky H, Bogduk N (Eds). Task Force on Taxonomy, 2nd ed. Seattle: IASP; 1994: 209–14.
Jasmin L, Rabkin SD, Granato A, Boudah A, Ohara PT. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 2003; 424: 316–20.
Klees TM, Brodtkorb E, Nakken KO, Lossius R, Johannessen SI. Clinical experience with the new antiepileptic drug levetiracetam. Acta Neurol Scand 2003; 107: 428.
Olat H, Cesaro P. Pharmacology of neuropathic pain. Clin Neuropharmacol 1995; 18: 391–404.
Pappagallo M. Neuropathic pain in peripheral neuropathies. In: Tollison CD, Satterthwaite JR, Tollison JW (Eds). Practical Pain Management, 3rd ed. Philidelphia, PA: Lippincott-Williams & Wilkins; 2002: 431–48.
Price D. Psychological Mechanisms of Pain and Analgesia. Progress in Pain Research and Management, vol 15. Seattle, WA: IASP; 1999.
Rigo JM, Hans G, Nguyen L, et al. The antiepileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABAand glycinegated currents. Br J Pharmacol 2002; 136: 656–72.
Siddall PJ, Cousins MJ. Introduction to pain mechanisms: implications for neural blockade. In: Cousins MJ, Bridenbaugh PO (Eds). Neural Blockade In Clinical Anesthesia and Management of Pain, 3rd ed. Philidelphia, PA: Lippincott-Raven; 1998: 675–713.
Sindrup SH, Jensen TS. Efficacy of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83: 85–6.
White HS. Comparative anticonvulsant and mechanistic profiles of the established and newer antiepileptic drugs. Epilepsia 1999; 40(suppl 5): S2–10.
Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959–64.
Ossipov MH, LaiJ, Vanderah TW, Porreca F. Induction of pain facilitation bt sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci 2003; 73: 783–800.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dunteman, E.D. Mechanisms and treatment issues for neuropathic pain. Can J Anesth 51 (Suppl 1), R46–R49 (2004). https://doi.org/10.1007/BF03018341
Issue Date:
DOI: https://doi.org/10.1007/BF03018341